Purpose 68 Ga-prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) is valuable for detecting primary and recurrent …

Background/Aim: To evaluate the diagnostic accuracy of 68Ga-prostate-specific membrane
antigen (PSMA) positron emission tomography/computed tomography (PET/CT) vs …

The purpose of this study was to investigate the feasibility and diagnostic efficacy of 68Ga-
prostate-specific membrane antigen (PSMA) PET/CT combined with PET/ultrasound-guided …

Materials and methods: From January 2021 to June 2022, 100 patients (median age: 66
years) with negative digital rectal examination underwent transperineal prostate biopsy for …

Purpose Ultrasound-guided biopsy (US biopsy) with 10–12 cores has a suboptimal
sensitivity for clinically significant prostate cancer (sigPCa). If US biopsy is negative …

Purpose To assess the diagnostic performance of 68 Ga-PSMA PET/CT for detecting
suspected prostate cancer (PCa) and to compare it with that of two cancer-predicting …

Background 68Ga prostate specific membrane antigen PET/CT (68Ga-PSMA PET/CT) may
be superior to multiparametric MRI (mpMRI) for localisation of prostate cancer tumour foci …

Abstract Introduction/Background To evaluate the accuracy of 68Ga-PSMA PET/CT versus
mpMRI targeted biopsy (TPBx) in the diagnosis of clinically significant prostate cancer …

Background/Aim: To evaluate the diagnostic accuracy of 68Ga-prostate-specific membrane
antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in the …

Clinically significant prostate cancer (csPCa) is the focus of clinical diagnosis and treatment
of prostate cancer (PCa). The current standard for diagnosing csPCa in men at risk relies on …